Healthcare AI IPOs
9 healthcare ai companies tracking toward an IPO in 2026.
Abridge
Abridge develops AI-powered medical conversation technology that helps healthcare providers automatically generate clinical documentation from patient encounters. The company's platform uses natural language processing to transform doctor-patient conversations into structured medical records, potentially saving physicians significant time.
Ambience Healthcare
Ambience Healthcare develops AI-powered tools for healthcare documentation and clinical workflows, helping doctors and healthcare systems automate administrative tasks and improve patient care efficiency. The company has attracted significant venture funding and attention in the rapidly growing healthcare AI sector.
ConcertAI
ConcertAI is a healthcare technology company that uses artificial intelligence and real-world data to accelerate drug development and improve patient outcomes. The company provides AI-powered solutions to pharmaceutical companies, health systems, and life sciences organizations for clinical research and precision medicine.
Hippocratic AI
Hippocratic AI is developing AI-powered healthcare solutions, focusing on creating large language models specifically designed for medical applications. The company aims to improve healthcare delivery through AI assistants that can handle various medical tasks safely and effectively. Investors are interested in the company's potential to address healthcare staffing challenges and improve patient outcomes through specialized medical AI.
Infinitus Systems
Infinitus Systems develops voice AI technology for healthcare, enabling healthcare workers to complete tasks through voice commands and natural language processing. The company's platform helps streamline administrative workflows in hospitals and healthcare systems, potentially reducing documentation burden on medical staff.
OpenEvidence
OpenEvidence is a platform that provides evidence-based research and analysis tools for healthcare and scientific decision-making. The company leverages AI and data analytics to help researchers and healthcare professionals access and interpret medical literature more efficiently. Investors may be interested in its potential to streamline evidence-based medicine workflows.
Suki
Suki develops AI-powered voice assistants specifically designed for healthcare professionals to streamline clinical documentation and administrative tasks. The company's technology helps doctors reduce time spent on paperwork by automatically generating clinical notes and managing electronic health records through voice commands.
Tempus
Tempus is a precision medicine company that uses artificial intelligence and machine learning to analyze clinical and molecular data to help physicians make more informed treatment decisions for cancer and other diseases. The company combines genomic sequencing, clinical data, and AI to provide insights for personalized medicine. Investors are interested in Tempus due to the growing importance of precision medicine and the company's data-driven approach to healthcare.
Tempus AI
Tempus AI is a precision medicine company that uses artificial intelligence and data analytics to help physicians make more informed treatment decisions, particularly in oncology. The company builds and operates a platform that analyzes clinical and molecular data to provide personalized therapy recommendations. Investors are interested in its potential to transform cancer care through AI-driven insights and its growing database of genomic and clinical information.
Track Healthcare AI IPOs
Get daily alerts when healthcare ai companies file S-1s or announce IPO dates.
Get IPO Alerts